comparemela.com

Latest Breaking News On - Carlos santos gallego - Page 2 : comparemela.com

Biomarker Predicts Survival in Pulmonary Arterial Hypertension

Plasma cell-free DNA, a marker of cellular injury, is elevated in patients with pulmonary arterial hypertension, correlates with disease severity, and predicts worse survival, new research shows.

New yorkUnited statesNational institutes of healthCarlos santos gallegoAmerican heart associationNational heartTufts medical centerBlood institute cardiovascular branchNational institutesAmerican heartDrug administration approvedAllegheny general hospitalEvaluate earlyMedscape cardiologyMount sinai hospitalNew york city

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

The shunt, designed to relieve pulmonary capillary wedge pressure, was no better than a sham procedure, researchers said.

New yorkUnited statesNew zealandCarlos santos gallegoHorst sievertSanjiv shahJoann lindenfeldPhilipp lurzResponder groupMd northwestern university feinberg school of medicineAmerican heart associationPhd university of leipzigCardiovascular center frankfurtMd vanderbilt university medical centerKansas city cardiomyopathy questionnaireNorthwestern university feinberg school

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

The pooled analysis from SCORED/SOLOIST-WHF hints at a potential reduction in CV death, but more data are needed.

New yorkUnited statesThomas maddoxCarlos santos gallegoDeepakl bhattLexicon pharmaceuticalsAmerican college of cardiologyDrug administrationBoehringer ingelheimMd washington university school of medicineAmerican collegeIcahn schoolMount sinaiWashington university schoolபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்

vimarsana © 2020. All Rights Reserved.